|
Contents
|
|
|
|
Brain
Tumors |
|
|
|
|
Piastra M, Di Rocco C, Caresta E, Zorzi G, De
Luca D, Caldarelli M, La Torre G, Conti G, Antonelli M, Eaton S, Pietrini D
Blood loss and short-term outcome of infants undergoing brain tumour
removal
J Neurooncol. 2008 Jul 10; [Epub ahead of print]
.JPG) Abstract
|
|
|
Cancer
Research |
|
|
|
Pediatric Patients
Bassem I. Razzouk, Jeffrey
D. Hord, Marilyn Hockenberry, Pamela S. Hinds,
James Feusner, Denise Williams, Wayne R.
Rackoff
Double-Blind, Placebo-Controlled Study of
Quality of Life, Hematologic End Points, and Safety of Weekly Epoetin Alfa
in Children With Cancer Receiving Myelosuppressive Chemotherapy
Journal of Clinical Oncology, Vol 24, No 22 (August 1), 2006: pp.
3583-3589, DOI: 10.1200/JCO.2005.03.4371
|
|
|
J A Glaspy, J S Jadeja, G Justice, J Kessler, D
Richards, L Schwartzberg, NS Tchekmedyian, S Armstrong, J O'Byrne,
G Rossi and A B Colowick
Darbepoetin alfa given
every 1 or 2 weeks alleviates anaemia associated withcancer chemotherapy
British Journal of Cancer, 29 July 2002, Volume 87, Number 3, Pages 268-276
Abstract
|
|
|
Michael S. Gordon
Managing Anemia in the Cancer Patient: Old Problems, Future Solutions
The Oncologist, Vol. 7, No. 4, 331-341, August 2002
Abstract |
.png) Full Text |
.png) Reprint
|
|
Green
MD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI,
Samonigg H, Clemens MR, Zani V, Liang BC, Renwick J, Piccart MJ
A randomized double-blind multicenter phase III study
of fixed-dose single-administration pegfilgrastim versus daily filgrastim in
patients receiving myelosuppressive chemotherapy
Ann Oncol 2003 Jan;14(1):29-35
|
|
Hans-Peter Kiem, Tobias Neff, Brian C. Beard, Laura J.
Peterson, Bobbie M. Thomasson, Jess Thompson
Gene Therapy To Protect Hematopoietic Cells From Cytotoxic
Chemotherapy In A Clinically Relevant Large Animal Model
Proceedings of the AACR, Volume 45, March 2004, Abstract
Number: LB-284
|
|
Kuttan G, Kuttan R
Reduction
of leukopenia in mice by "viscum album" administration during
radiation and chemotherapy
Tumori 1993 Feb
28;79(1):74-6
|
|
Salvatore Siena, Simona
Secondino, Laura Giannetta, Ornella Carminati and Paolo Pedrazzoli
Optimising
management of neutropenia and anaemia in cancer chemotherapy––advances
in cytokine therapy
Critical Reviews
in Oncology/Hematology, Vol. 48, Suppl. 1, 15 Oct. 2003, Pages S39-S47 (Review Article,
Abstract)
|
|
|
David P. Steensma, Roy
Molina, Jeff A. Sloan, Daniel A. Nikcevich,
Paul L. Schaefer, Kendrith M. Rowland, Jr, Todor
Dentchev, Paul J. Novotny, Loren K. Tschetter,
Steven R. Alberts, Thomas F. Hogan, Amy
Law, Charles L. Loprinzi
Phase III
Study of Two Different Dosing Schedules of Erythropoietin in Anemic
Patients With Cancer
Journal of Clinical Oncology, Vol 24, No 7 (March 1), 2006: pp. 1079-1089;
DOI: 10.1200/JCO.2005.02.7276
Abstract |
Full
Text |
Reprint
| .gif)
News
|
|
|
Benny Chung-Ying Zee
Planned
Equivalence or Noninferiority Trials Versus Unplanned Noninferiority
Claims: Are They Equal
Journal of Clinical Oncology, Vol 24, No 7 (March 1), 2006: pp. 1026-1028;
DOI: 10.1200/JCO.2005.04.9684
Full Text |
Reprint
|
|
|
Glioblastoma |
|
|
|
|
Kopecký J, Priester P,
Slovácek L, Petera J, Kopecký O, Macingova Z.
Aplastic anemia as a cause of death in a patient with glioblastoma
multiforme treated with temozolomide
Strahlenther Onkol. 2010 Aug;186(8):452-7
Abstract
|
|
|
Nagane M, Nozue K, Shimizu S, Waha A, Miyazaki
H, Kurita H, Homori M, Fujioka Y, Shiokawa Y
Prolonged
and severe thrombocytopenia with pancytopenia induced by radiation-combined
temozolomide therapy in a patient with newly diagnosed glioblastoma-analysis
of O (6)-methylguanine-DNA methyltransferase status
J Neurooncol.
2008 Nov 27. [Epub ahead of print]
Abstract
|
|
|
Pehlivan
Y, Sevinc A, Turkbeyler IH, Dirier A, Kalender ME, Camci C.
Another cause of pancytopenia
in a patient receiving temozolomide.
Med Princ Pract. 2011;20(4):377-9.
Epub 2011 May 11.
Abstract |
.gif) Related articles
|
|
|
van Durme CM, Idema RN, van Guldener C.
Two rare complications of glioblastoma multiforme: persistent hiccup and
acquired haemophilia A
Neth J Med. 2008 Jul-Aug;66(7):286-8
Abstract |
Reprint
|
|
|
Gliomas |
|
|
|
|
Chamberlain MC, Raizer J.
Extended exposure to alkylator chemotherapy: delayed appearance of
myelodysplasia
J Neurooncol. 2008 Dec 20; [Epub ahead of print]
Abstract
|
|
|
Grossman SA, Ye X, Lesser G, Sloan AE, Carraway HE, Desideri S, Piantadosi
S.
Immunosuppression
in Patients with High Grade Gliomas Treated with Radiation and Temozolomide.
Clin
Cancer Res. 2011 Jul 7. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Ishikawa
E, Yamamoto T, Sakamoto N, Nakai K, Akutsu H, Tsuboi K, Takano S, Matsumura
A
Low peripheral lymphocyte count before focal radiotherapy plus concomitant
temozolomide predicts severe lymphopenia during malignant glioma treatment
Neurol Med Chir (Tokyo). 2010;50(8):638-44
Abstract |
Reprint | Related articles
|
|
Lenartz
D, Stoffel B, Menzel J, Beuth J.
Immunoprotective
activity of the galactoside-specific lectin from mistletoe after tumor
destructive therapy in glioma patients
Anticancer
Res 1996 Nov-Dec;16(6B):3799-802
|
|
|
Norden AD, Bartolomeo J, Tanaka S, Drappatz J, Ciampa AS, Doherty LM,
Lafrankie DC, Ruland S, Quant EC, Beroukhim R, Wen PY.
Safety
of concurrent bevacizumab therapy and anticoagulation in glioma patients.
J Neurooncol.
2011 Jun 26. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Shah
GD, Silver JS, Rosenfeld SS, Gavrilovic IT, Abrey LE, Lassman AB.
Myelosuppression in patients benefiting from imatinib with hydroxyurea for
recurrent malignant gliomas.
J Neurooncol.
2007 Jun 27; [Epub ahead of print]
PMID: 17594055 [PubMed - as supplied by publisher]
|
|
|
Singhal N, Selva-Nayagam S, Brown MP.
Prolonged and severe myelosuppression in two patients after low-dose
temozolomide treatment- case study and review of literature
J Neurooncol.
2007 Nov;85(2):229-30.
Epub 2007 May 26
Abstract |
Reprint
|
|
|
Oligodendroglioma
|
|
|
|
Vanita Noronha, Nancy Berliner,
Karen K. Ballen, Jill Lacy, Jean Kracher,
Joachim Baehring and John W. Henson
Treatment-related myelodysplasia/AML in a patient with a history of breast
cancer and an oligodendroglioma treated with temozolomide: Case study and review
of the literature
Neuro-oncol 2006 Jul 1; 8(3):280-283; Epub 2006 May 25
Abstract
|
|
|
|
